Global Non-small Cell Lung Cancer Therapeutics Sales Market Report 2018

June 2018 | 105 pages | ID: GB30C69406EEN
QYResearch

Abstracts

This report studies the global Non-small Cell Lung Cancer Therapeutics market status and forecast, categorizes the global Non-small Cell Lung Cancer Therapeutics market size (value & volume) by key players, type, application, and region.
This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers.

The global Non-small Cell Lung Cancer Therapeutics market is valued at 6660 million US$ in 2017 and will reach 11900 million US$ by the end of 2025, growing at a CAGR of 7.5% during 2018-2025.
The major players covered in this report

• GlaxoSmithKline
• Novartis
• AstraZeneca
• Roche
• Bristol-Myers Squibb
• Pfizer
• Eli Lilly
• Sanofi

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

• United States
• Europe
• China
• Japan
• Southeast Asia
• India

We can also provide the customized separate regional or country-level reports, for the following regions:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Singapore
• Rest of Asia-Pacific
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
• Central & South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Saudi Arabia
• Turkey
• Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Alimta
• Iressa
• Avastin
• Tarceva
• Zykadia
• Tagrisso
• Xalkori
• Cyramza
• Opdivo
• Alecensa

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinic

The study objectives of this report are:

• To analyze and study the global Non-small Cell Lung Cancer Therapeutics sales, value, status (2013-2017) and forecast (2018-2025);
• To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
• Focuses on the key Non-small Cell Lung Cancer Therapeutics players, to study the sales, value, market share and development plans in future.
• Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Non-small Cell Lung Cancer Therapeutics are as follows:

• History Year: 2013-2017
• Base Year: 2017
• Estimated Year: 2018
• Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Non-small Cell Lung Cancer Therapeutics Manufacturers
Non-small Cell Lung Cancer Therapeutics Distributors/Traders/Wholesalers
Non-small Cell Lung Cancer Therapeutics Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Non-small Cell Lung Cancer Therapeutics market, by end-use.
Detailed analysis and profiles of additional market players.

Contents

Global Non-small Cell Lung Cancer Therapeutics Sales Market Report 2018

1 NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET OVERVIEW

1.1 Product Overview and Scope of Non-small Cell Lung Cancer Therapeutics
1.2 Classification of Non-small Cell Lung Cancer Therapeutics by Product Category
  1.2.1 Global Non-small Cell Lung Cancer Therapeutics Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 Global Non-small Cell Lung Cancer Therapeutics Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Alimta
  1.2.4 Iressa
  1.2.5 Avastin
  1.2.6 Tarceva
  1.2.7 Zykadia
  1.2.8 Tagrisso
  1.2.9 Xalkori
  1.2.10 Cyramza
  1.2.11 Opdivo
  1.2.12 Alecensa
1.3 Global Non-small Cell Lung Cancer Therapeutics Market by Application/End Users
  1.3.1 Global Non-small Cell Lung Cancer Therapeutics Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.1 Hospital
  1.3.2 Clinic
1.4 Global Non-small Cell Lung Cancer Therapeutics Market by Region
  1.4.1 Global Non-small Cell Lung Cancer Therapeutics Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 United States Non-small Cell Lung Cancer Therapeutics Status and Prospect (2013-2025)
  1.4.3 Europe Non-small Cell Lung Cancer Therapeutics Status and Prospect (2013-2025)
  1.4.4 China Non-small Cell Lung Cancer Therapeutics Status and Prospect (2013-2025)
  1.4.5 Japan Non-small Cell Lung Cancer Therapeutics Status and Prospect (2013-2025)
  1.4.6 Southeast Asia Non-small Cell Lung Cancer Therapeutics Status and Prospect (2013-2025)
  1.4.7 India Non-small Cell Lung Cancer Therapeutics Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Non-small Cell Lung Cancer Therapeutics (2013-2025)
  1.5.1 Global Non-small Cell Lung Cancer Therapeutics Sales and Growth Rate (2013-2025)
  1.5.2 Global Non-small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2025)

2 GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Non-small Cell Lung Cancer Therapeutics Market Competition by Players/Suppliers
  2.1.1 Global Non-small Cell Lung Cancer Therapeutics Sales and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Global Non-small Cell Lung Cancer Therapeutics Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Non-small Cell Lung Cancer Therapeutics (Volume and Value) by Type
  2.2.1 Global Non-small Cell Lung Cancer Therapeutics Sales and Market Share by Type (2013-2018)
  2.2.2 Global Non-small Cell Lung Cancer Therapeutics Revenue and Market Share by Type (2013-2018)
2.3 Global Non-small Cell Lung Cancer Therapeutics (Volume and Value) by Region
  2.3.1 Global Non-small Cell Lung Cancer Therapeutics Sales and Market Share by Region (2013-2018)
  2.3.2 Global Non-small Cell Lung Cancer Therapeutics Revenue and Market Share by Region (2013-2018)
2.4 Global Non-small Cell Lung Cancer Therapeutics (Volume) by Application

3 UNITED STATES NON-SMALL CELL LUNG CANCER THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Non-small Cell Lung Cancer Therapeutics Sales and Value (2013-2018)
  3.1.1 United States Non-small Cell Lung Cancer Therapeutics Sales and Growth Rate (2013-2018)
  3.1.2 United States Non-small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018)
  3.1.3 United States Non-small Cell Lung Cancer Therapeutics Sales Price Trend (2013-2018)
3.2 United States Non-small Cell Lung Cancer Therapeutics Sales Volume and Market Share by Players (2013-2018)
3.3 United States Non-small Cell Lung Cancer Therapeutics Sales Volume and Market Share by Type (2013-2018)
3.4 United States Non-small Cell Lung Cancer Therapeutics Sales Volume and Market Share by Application (2013-2018)

4 EUROPE NON-SMALL CELL LUNG CANCER THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

4.1 Europe Non-small Cell Lung Cancer Therapeutics Sales and Value (2013-2018)
  4.1.1 Europe Non-small Cell Lung Cancer Therapeutics Sales and Growth Rate (2013-2018)
  4.1.2 Europe Non-small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018)
  4.1.3 Europe Non-small Cell Lung Cancer Therapeutics Sales Price Trend (2013-2018)
4.2 Europe Non-small Cell Lung Cancer Therapeutics Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Non-small Cell Lung Cancer Therapeutics Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Non-small Cell Lung Cancer Therapeutics Sales Volume and Market Share by Application (2013-2018)

5 CHINA NON-SMALL CELL LUNG CANCER THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

5.1 China Non-small Cell Lung Cancer Therapeutics Sales and Value (2013-2018)
  5.1.1 China Non-small Cell Lung Cancer Therapeutics Sales and Growth Rate (2013-2018)
  5.1.2 China Non-small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018)
  5.1.3 China Non-small Cell Lung Cancer Therapeutics Sales Price Trend (2013-2018)
5.2 China Non-small Cell Lung Cancer Therapeutics Sales Volume and Market Share by Players (2013-2018)
5.3 China Non-small Cell Lung Cancer Therapeutics Sales Volume and Market Share by Type (2013-2018)
5.4 China Non-small Cell Lung Cancer Therapeutics Sales Volume and Market Share by Application (2013-2018)

6 JAPAN NON-SMALL CELL LUNG CANCER THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Non-small Cell Lung Cancer Therapeutics Sales and Value (2013-2018)
  6.1.1 Japan Non-small Cell Lung Cancer Therapeutics Sales and Growth Rate (2013-2018)
  6.1.2 Japan Non-small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018)
  6.1.3 Japan Non-small Cell Lung Cancer Therapeutics Sales Price Trend (2013-2018)
6.2 Japan Non-small Cell Lung Cancer Therapeutics Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Non-small Cell Lung Cancer Therapeutics Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Non-small Cell Lung Cancer Therapeutics Sales Volume and Market Share by Application (2013-2018)

7 SOUTHEAST ASIA NON-SMALL CELL LUNG CANCER THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Non-small Cell Lung Cancer Therapeutics Sales and Value (2013-2018)
  7.1.1 Southeast Asia Non-small Cell Lung Cancer Therapeutics Sales and Growth Rate (2013-2018)
  7.1.2 Southeast Asia Non-small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018)
  7.1.3 Southeast Asia Non-small Cell Lung Cancer Therapeutics Sales Price Trend (2013-2018)
7.2 Southeast Asia Non-small Cell Lung Cancer Therapeutics Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Non-small Cell Lung Cancer Therapeutics Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Non-small Cell Lung Cancer Therapeutics Sales Volume and Market Share by Application (2013-2018)

8 INDIA NON-SMALL CELL LUNG CANCER THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

8.1 India Non-small Cell Lung Cancer Therapeutics Sales and Value (2013-2018)
  8.1.1 India Non-small Cell Lung Cancer Therapeutics Sales and Growth Rate (2013-2018)
  8.1.2 India Non-small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018)
  8.1.3 India Non-small Cell Lung Cancer Therapeutics Sales Price Trend (2013-2018)
8.2 India Non-small Cell Lung Cancer Therapeutics Sales Volume and Market Share by Players (2013-2018)
8.3 India Non-small Cell Lung Cancer Therapeutics Sales Volume and Market Share by Type (2013-2018)
8.4 India Non-small Cell Lung Cancer Therapeutics Sales Volume and Market Share by Application (2013-2018)

9 GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 GlaxoSmithKline
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Non-small Cell Lung Cancer Therapeutics Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  9.1.4 Main Business/Business Overview
9.2 Novartis
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Non-small Cell Lung Cancer Therapeutics Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Novartis Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  9.2.4 Main Business/Business Overview
9.3 AstraZeneca
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Non-small Cell Lung Cancer Therapeutics Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 AstraZeneca Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  9.3.4 Main Business/Business Overview
9.4 Roche
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Non-small Cell Lung Cancer Therapeutics Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Roche Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  9.4.4 Main Business/Business Overview
9.5 Bristol-Myers Squibb
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Non-small Cell Lung Cancer Therapeutics Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Bristol-Myers Squibb Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  9.5.4 Main Business/Business Overview
9.6 Pfizer
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Non-small Cell Lung Cancer Therapeutics Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Pfizer Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  9.6.4 Main Business/Business Overview
9.7 Eli Lilly
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Non-small Cell Lung Cancer Therapeutics Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Eli Lilly Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  9.7.4 Main Business/Business Overview
9.8 Sanofi
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Non-small Cell Lung Cancer Therapeutics Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Sanofi Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  9.8.4 Main Business/Business Overview

10 NON-SMALL CELL LUNG CANCER THERAPEUTICS MAUFACTURING COST ANALYSIS

10.1 Non-small Cell Lung Cancer Therapeutics Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Non-small Cell Lung Cancer Therapeutics
10.3 Manufacturing Process Analysis of Non-small Cell Lung Cancer Therapeutics

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Non-small Cell Lung Cancer Therapeutics Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Non-small Cell Lung Cancer Therapeutics Major Manufacturers in 2017
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET FORECAST (2018-2025)

14.1 Global Non-small Cell Lung Cancer Therapeutics Sales Volume, Revenue and Price Forecast (2018-2025)
  14.1.1 Global Non-small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate Forecast (2018-2025)
  14.1.2 Global Non-small Cell Lung Cancer Therapeutics Revenue and Growth Rate Forecast (2018-2025)
  14.1.3 Global Non-small Cell Lung Cancer Therapeutics Price and Trend Forecast (2018-2025)
14.2 Global Non-small Cell Lung Cancer Therapeutics Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  14.2.1 Global Non-small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate Forecast by Regions (2018-2025)
  14.2.2 Global Non-small Cell Lung Cancer Therapeutics Revenue and Growth Rate Forecast by Regions (2018-2025)
  14.2.3 United States Non-small Cell Lung Cancer Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.4 Europe Non-small Cell Lung Cancer Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.5 China Non-small Cell Lung Cancer Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.6 Japan Non-small Cell Lung Cancer Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.7 Southeast Asia Non-small Cell Lung Cancer Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.8 India Non-small Cell Lung Cancer Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Non-small Cell Lung Cancer Therapeutics Sales Volume, Revenue and Price Forecast by Type (2018-2025)
  14.3.1 Global Non-small Cell Lung Cancer Therapeutics Sales Forecast by Type (2018-2025)
  14.3.2 Global Non-small Cell Lung Cancer Therapeutics Revenue Forecast by Type (2018-2025)
  14.3.3 Global Non-small Cell Lung Cancer Therapeutics Price Forecast by Type (2018-2025)
14.4 Global Non-small Cell Lung Cancer Therapeutics Sales Volume Forecast by Application (2018-2025)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Non-small Cell Lung Cancer Therapeutics
Figure Global Non-small Cell Lung Cancer Therapeutics Sales Volume Comparison (K Units) by Type (2013-2025)
Figure Global Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Type (Product Category) in 2017
Figure Alimta Product Picture
Figure Iressa Product Picture
Figure Avastin Product Picture
Figure Tarceva Product Picture
Figure Zykadia Product Picture
Figure Tagrisso Product Picture
Figure Xalkori Product Picture
Figure Cyramza Product Picture
Figure Opdivo Product Picture
Figure Alecensa Product Picture
Figure Global Non-small Cell Lung Cancer Therapeutics Sales Comparison (K Units) by Application (2013-2025)
Figure Global Sales Market Share of Non-small Cell Lung Cancer Therapeutics by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Global Non-small Cell Lung Cancer Therapeutics Market Size (Million USD) by Regions (2013-2025)
Figure United States Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Non-small Cell Lung Cancer Therapeutics Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Global Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Non-small Cell Lung Cancer Therapeutics Sales Volume (K Units) (2013-2018)
Table Global Non-small Cell Lung Cancer Therapeutics Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Global Non-small Cell Lung Cancer Therapeutics Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Non-small Cell Lung Cancer Therapeutics Sales Share by Players/Suppliers
Figure 2017 Non-small Cell Lung Cancer Therapeutics Sales Share by Players/Suppliers
Figure Global Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Non-small Cell Lung Cancer Therapeutics Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Non-small Cell Lung Cancer Therapeutics Revenue Share by Players
Table 2017 Global Non-small Cell Lung Cancer Therapeutics Revenue Share by Players
Table Global Non-small Cell Lung Cancer Therapeutics Sales (K Units) and Market Share by Type (2013-2018)
Table Global Non-small Cell Lung Cancer Therapeutics Sales Share (K Units) by Type (2013-2018)
Figure Sales Market Share of Non-small Cell Lung Cancer Therapeutics by Type (2013-2018)
Figure Global Non-small Cell Lung Cancer Therapeutics Sales Growth Rate by Type (2013-2018)
Table Global Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Non-small Cell Lung Cancer Therapeutics Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Non-small Cell Lung Cancer Therapeutics by Type (2013-2018)
Figure Global Non-small Cell Lung Cancer Therapeutics Revenue Growth Rate by Type (2013-2018)
Table Global Non-small Cell Lung Cancer Therapeutics Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Global Non-small Cell Lung Cancer Therapeutics Sales Share by Region (2013-2018)
Figure Sales Market Share of Non-small Cell Lung Cancer Therapeutics by Region (2013-2018)
Figure Global Non-small Cell Lung Cancer Therapeutics Sales Growth Rate by Region in 2017
Table Global Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Non-small Cell Lung Cancer Therapeutics Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Non-small Cell Lung Cancer Therapeutics by Region (2013-2018)
Figure Global Non-small Cell Lung Cancer Therapeutics Revenue Growth Rate by Region in 2017
Table Global Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Non-small Cell Lung Cancer Therapeutics Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Non-small Cell Lung Cancer Therapeutics by Region (2013-2018)
Figure Global Non-small Cell Lung Cancer Therapeutics Revenue Market Share by Region in 2017
Table Global Non-small Cell Lung Cancer Therapeutics Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Global Non-small Cell Lung Cancer Therapeutics Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Non-small Cell Lung Cancer Therapeutics by Application (2013-2018)
Figure Global Non-small Cell Lung Cancer Therapeutics Sales Market Share by Application (2013-2018)
Figure United States Non-small Cell Lung Cancer Therapeutics Sales (K Units) and Growth Rate (2013-2018)
Figure United States Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Non-small Cell Lung Cancer Therapeutics Sales Price (USD/Unit) Trend (2013-2018)
Table United States Non-small Cell Lung Cancer Therapeutics Sales Volume (K Units) by Players (2013-2018)
Table United States Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Players (2013-2018)
Figure United States Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Players in 2017
Table United States Non-small Cell Lung Cancer Therapeutics Sales Volume (K Units) by Type (2013-2018)
Table United States Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Type (2013-2018)
Figure United States Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Type in 2017
Table United States Non-small Cell Lung Cancer Therapeutics Sales Volume (K Units) by Application (2013-2018)
Table United States Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Application (2013-2018)
Figure United States Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Application in 2017
Figure Europe Non-small Cell Lung Cancer Therapeutics Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Non-small Cell Lung Cancer Therapeutics Sales Price (USD/Unit) Trend (2013-2018)
Table Europe Non-small Cell Lung Cancer Therapeutics Sales Volume (K Units) by Players (2013-2018)
Table Europe Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Players (2013-2018)
Figure Europe Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Players in 2017
Table Europe Non-small Cell Lung Cancer Therapeutics Sales Volume (K Units) by Type (2013-2018)
Table Europe Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Type (2013-2018)
Figure Europe Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Type in 2017
Table Europe Non-small Cell Lung Cancer Therapeutics Sales Volume (K Units) by Application (2013-2018)
Table Europe Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Application (2013-2018)
Figure Europe Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Application in 2017
Figure China Non-small Cell Lung Cancer Therapeutics Sales (K Units) and Growth Rate (2013-2018)
Figure China Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Non-small Cell Lung Cancer Therapeutics Sales Price (USD/Unit) Trend (2013-2018)
Table China Non-small Cell Lung Cancer Therapeutics Sales Volume (K Units) by Players (2013-2018)
Table China Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Players (2013-2018)
Figure China Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Players in 2017
Table China Non-small Cell Lung Cancer Therapeutics Sales Volume (K Units) by Type (2013-2018)
Table China Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Type (2013-2018)
Figure China Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Type in 2017
Table China Non-small Cell Lung Cancer Therapeutics Sales Volume (K Units) by Application (2013-2018)
Table China Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Application (2013-2018)
Figure China Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Application in 2017
Figure Japan Non-small Cell Lung Cancer Therapeutics Sales (K Units) and Growth Rate (2013-2018)
Figure Japan Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Non-small Cell Lung Cancer Therapeutics Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Non-small Cell Lung Cancer Therapeutics Sales Volume (K Units) by Players (2013-2018)
Table Japan Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Players (2013-2018)
Figure Japan Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Players in 2017
Table Japan Non-small Cell Lung Cancer Therapeutics Sales Volume (K Units) by Type (2013-2018)
Table Japan Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Type (2013-2018)
Figure Japan Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Type in 2017
Table Japan Non-small Cell Lung Cancer Therapeutics Sales Volume (K Units) by Application (2013-2018)
Table Japan Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Application (2013-2018)
Figure Japan Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Application in 2017
Figure Southeast Asia Non-small Cell Lung Cancer Therapeutics Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Non-small Cell Lung Cancer Therapeutics Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Non-small Cell Lung Cancer Therapeutics Sales Volume (K Units) by Players (2013-2018)
Table Southeast Asia Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Players in 2017
Table Southeast Asia Non-small Cell Lung Cancer Therapeutics Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Type in 2017
Table Southeast Asia Non-small Cell Lung Cancer Therapeutics Sales Volume (K Units) by Application (2013-2018)
Table Southeast Asia Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Application in 2017
Figure India Non-small Cell Lung Cancer Therapeutics Sales (K Units) and Growth Rate (2013-2018)
Figure India Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Non-small Cell Lung Cancer Therapeutics Sales Price (USD/Unit) Trend (2013-2018)
Table India Non-small Cell Lung Cancer Therapeutics Sales Volume (K Units) by Players (2013-2018)
Table India Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Players (2013-2018)
Figure India Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Players in 2017
Table India Non-small Cell Lung Cancer Therapeutics Sales Volume (K Units) by Type (2013-2018)
Table India Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Type (2013-2018)
Figure India Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Type in 2017
Table India Non-small Cell Lung Cancer Therapeutics Sales Volume (K Units) by Application (2013-2018)
Table India Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Application (2013-2018)
Figure India Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share by Application in 2017
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Sales Global Market Share (2013-2018)
Figure GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Revenue Global Market Share (2013-2018)
Table Novartis Basic Information List
Table Novartis Non-small Cell Lung Cancer Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Non-small Cell Lung Cancer Therapeutics Sales Growth Rate (2013-2018)
Figure Novartis Non-small Cell Lung Cancer Therapeutics Sales Global Market Share (2013-2018)
Figure Novartis Non-small Cell Lung Cancer Therapeutics Revenue Global Market Share (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca Non-small Cell Lung Cancer Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca Non-small Cell Lung Cancer Therapeutics Sales Growth Rate (2013-2018)
Figure AstraZeneca Non-small Cell Lung Cancer Therapeutics Sales Global Market Share (2013-2018
Figure AstraZeneca Non-small Cell Lung Cancer Therapeutics Revenue Global Market Share (2013-2018)
Table Roche Basic Information List
Table Roche Non-small Cell Lung Cancer Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Roche Non-small Cell Lung Cancer Therapeutics Sales Growth Rate (2013-2018)
Figure Roche Non-small Cell Lung Cancer Therapeutics Sales Global Market Share (2013-2018)
Figure Roche Non-small Cell Lung Cancer Therapeutics Revenue Global Market Share (2013-2018)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Non-small Cell Lung Cancer Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Non-small Cell Lung Cancer Therapeutics Sales Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Non-small Cell Lung Cancer Therapeutics Sales Global Market Share (2013-2018)
Figure Bristol-Myers Squibb Non-small Cell Lung Cancer Therapeutics Revenue Global Market Share (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Non-small Cell Lung Cancer Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Non-small Cell Lung Cancer Therapeutics Sales Growth Rate (2013-2018)
Figure Pfizer Non-small Cell Lung Cancer Therapeutics Sales Global Market Share (2013-2018
Figure Pfizer Non-small Cell Lung Cancer Therapeutics Revenue Global Market Share (2013-2018)
Table Eli Lilly Basic Information List
Table Eli Lilly Non-small Cell Lung Cancer Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eli Lilly Non-small Cell Lung Cancer Therapeutics Sales Growth Rate (2013-2018)
Figure Eli Lilly Non-small Cell Lung Cancer Therapeutics Sales Global Market Share (2013-2018)
Figure Eli Lilly Non-small Cell Lung Cancer Therapeutics Revenue Global Market Share (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Non-small Cell Lung Cancer Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi Non-small Cell Lung Cancer Therapeutics Sales Growth Rate (2013-2018)
Figure Sanofi Non-small Cell Lung Cancer Therapeutics Sales Global Market Share (2013-2018
Figure Sanofi Non-small Cell Lung Cancer Therapeutics Revenue Global Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-small Cell Lung Cancer Therapeutics
Figure Manufacturing Process Analysis of Non-small Cell Lung Cancer Therapeutics
Figure Non-small Cell Lung Cancer Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Non-small Cell Lung Cancer Therapeutics Major Players in 2017
Table Major Buyers of Non-small Cell Lung Cancer Therapeutics
Table Distributors/Traders List
Figure Global Non-small Cell Lung Cancer Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Non-small Cell Lung Cancer Therapeutics Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Non-small Cell Lung Cancer Therapeutics Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share Forecast by Regions in 2025
Table Global Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Non-small Cell Lung Cancer Therapeutics Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Non-small Cell Lung Cancer Therapeutics Revenue Market Share Forecast by Regions in 2025
Figure United States Non-small Cell Lung Cancer Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Non-small Cell Lung Cancer Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Non-small Cell Lung Cancer Therapeutics Revenue and Growth Rate Forecast (2018-2025)
Figure China Non-small Cell Lung Cancer Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Non-small Cell Lung Cancer Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Non-small Cell Lung Cancer Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Non-small Cell Lung Cancer Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Non-small Cell Lung Cancer Therapeutics Sales (K Units) Forecast by Type (2018-2025)
Figure Global Non-small Cell Lung Cancer Therapeutics Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Non-small Cell Lung Cancer Therapeutics Revenue Market Share Forecast by Type (2018-2025)
Table Global Non-small Cell Lung Cancer Therapeutics Price (USD/Unit) Forecast by Type (2018-2025)
Table Global Non-small Cell Lung Cancer Therapeutics Sales (K Units) Forecast by Application (2018-2025)
Figure Global Non-small Cell Lung Cancer Therapeutics Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources